• Targeting Cardiac Late Sodium Current in Aging: GS967 Insigh

  2026-07-25

  Aging-driven increases in cardiac late sodium current (INa,L) critically underpin diastolic dysfunction and arrhythmogenesis. This article unpacks the mechanistic basis for targeting INa,L—centering on Nav1.5 Ser571 phosphorylation—and offers actionable strategies for translational researchers. With reference to recent breakthroughs and the unique properties of GS967, we chart a roadmap for advanced cardiac electrophysiology workflows and highlight future directions for arrhythmia prevention research.

• Comparative Efficacy of Toremifene and Tamoxifen in Advanced

  2026-07-24

  This systematic review rigorously compares toremifene and tamoxifen for the management of advanced breast cancer, providing granular evidence on efficacy and safety outcomes. Findings clarify the relative therapeutic roles of these selective estrogen receptor modulators (SERMs), informing both clinical research and drug development in estrogen receptor signaling.

• EZ Cap™ Firefly Luciferase mRNA: Cap 1 Reporter for Efficien

  2026-07-24

  EZ Cap™ Firefly Luciferase mRNA is a capped mRNA tool optimized for bioluminescent reporting and high translation efficiency. Its Cap 1 structure and poly(A) tail enhance stability and expression, setting a benchmark for gene regulation and in vivo imaging studies.

• Afatinib (BIBW 2992): Advanced Assay Design in Tumor Microen

  2026-07-23

  Explore how Afatinib enables high-fidelity modeling of EGFR, HER2, and HER4 signaling in complex tumor microenvironments. This article uniquely bridges mechanistic insight with assay design for cancer biology research, highlighting practical strategies beyond current assembloid studies.

• Modeling Human SAN Maturation with PSC-Derived Cardiac Assem

  2026-07-23

  This study introduces a tri-assembloid platform integrating human PSC-derived sinoatrial node, cardiac plexus, and atrial organoids to model neuro-cardiac crosstalk in pacemaker maturation. The system enables functional analysis of neuron-to-pacemaker signaling, offering a new foundation for mechanistic studies of human heart rhythm and disease.

• Bazedoxifene as an IL-6/GP130 Pathway Inhibitor in Cancer Th

  2026-07-22

  This review systematically evaluates Bazedoxifene's capacity to inhibit the IL-6/GP130 signaling axis, a critical pathway in cancer progression. By repurposing this third-generation selective estrogen receptor modulator, the study opens new research directions beyond osteoporosis, highlighting Bazedoxifene's mechanistic versatility and potential in oncological applications.

• Fiber Density Guides Collagen Heterogeneity in Annulus Fibro

  2026-07-22

  This study demonstrates that scaffold fiber density is a decisive mechanobiological parameter for directing annulus fibrosus cell (AFC) collagen phenotype via distinct mechanotransductive pathways. The findings offer a blueprint for engineering biomaterials that more faithfully reconstruct the native collagen heterogeneity essential for intervertebral disc function.

• Kir4.1 Regulation of Panx3 via ROS-P38 MAPK in Orofacial Pai

  2026-07-21

  This study identifies inwardly rectifying potassium channel Kir4.1 as a regulator of pannexin 3 (Panx3) expression through the reactive oxygen species (ROS)-activated P38 MAPK pathway in trigeminal ganglia. The findings clarify key molecular events underlying orofacial neuropathic pain and suggest new targets for therapeutic intervention.

• Malate ((S)-2-hydroxysuccinic acid) in TCA Cycle Research

  2026-07-21

  Malate, a central TCA cycle intermediate, enables researchers to dissect mitochondrial metabolism and immunometabolic crosstalk with precision. Leveraging APExBIO's high-purity malate streamlines advanced workflows in cancer, immunology, and metabolic adaptation studies, offering reproducibility and protocol flexibility.

• Leptin (116-130), amide, mouse: Precision in Obesity Researc

  2026-07-20

  Leptin (116-130), amide, mouse, a potent adipocyte-derived hormone fragment from APExBIO, offers exceptional reproducibility and flexibility for dissecting metabolic and immunological pathways in obesity and diabetes research. This guide delivers stepwise workflows, troubleshooting strategies, and a practical synthesis of the latest reference findings to empower advanced experimental design.

• Bazedoxifene in Osteoporosis: Clinical Efficacy and Research

  2026-07-20

  The reference study systematically evaluates Bazedoxifene, a third-generation selective estrogen receptor modulator, for its long-term efficacy and safety in postmenopausal osteoporosis. Key findings include significant vertebral fracture risk reduction and modest lumbar spine bone mineral density gains, supporting its use in long-term therapeutic strategies.

• BRCA2 Suppresses PARP1 Retention to Protect RAD51 Filaments

  2026-07-19

  This study elucidates how BRCA2 prevents the retention of PARP1 at DNA damage sites following PARP inhibitor (PARPi) treatment, thereby stabilizing RAD51 filaments necessary for homologous recombination repair. The findings provide mechanistic clarity for the selective vulnerability of BRCA2-deficient tumors to PARP inhibition, informing strategies for homologous recombination deficient cancer treatment.

• Griseofulvin: Microtubule Associated Inhibitor in Fungal Mod

  2026-07-18

  Griseofulvin stands out as a precision microtubule associated inhibitor for dissecting fungal cell mitosis in experimental workflows. This article bridges the latest reference assay breakthroughs with practical protocol enhancements and troubleshooting tips, showcasing how APExBIO’s Griseofulvin enables reproducible, high-impact antifungal drug research.

• Nelfinavir Mesylate: Beyond HIV—A Gateway to Ferroptosis Res

  2026-07-17

  Explore how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, is transforming from antiretroviral mainstay to a key tool in ferroptosis and protein homeostasis research. This article uniquely dissects mechanistic insights and practical protocols for innovative cell death studies.

• Structural Basis of HCAR3-Selective Agonist Recognition Reve

  2026-07-17

  Ye et al. (2025) present high-resolution cryo-EM structures of HCAR3 bound to selective agonists, including Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid). Their work elucidates the molecular determinants of ligand selectivity, informing strategies for developing hypolipidemic agents with improved specificity and fewer side effects.

449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page